awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41955361-264EABA1-9BA0-4CB9-AC1A-E6C3ABE4E345
Q41955361-264EABA1-9BA0-4CB9-AC1A-E6C3ABE4E345
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41955361-264EABA1-9BA0-4CB9-AC1A-E6C3ABE4E345
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status.
P2860
Q41955361-264EABA1-9BA0-4CB9-AC1A-E6C3ABE4E345
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41955361-264EABA1-9BA0-4CB9-AC1A-E6C3ABE4E345
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57f4b69ce16862bbbb7a4289bd9d1010eb5266aa
P2860
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas